Search Results - "Alossaimi, Manal A"

Refine Results
  1. 1

    A Novel Quantum Dots-Based Fluorescent Sensor for Determination of the Anticancer Dacomitinib: Application to Dosage Forms by Alossaimi, Manal A, Elmansi, Heba, Alajaji, Mai, Altharawi, Ali, Altamimi, Abdulmalik S A, Magdy, Galal

    Published in Molecules (Basel, Switzerland) (01-03-2023)
    “…One of the most promising drugs recently approved for the treatment of various types of cancer is dacomitinib, which belongs to the tyrosine kinase inhibitor…”
    Get full text
    Journal Article
  2. 2

    Exploring Nanocarriers as Treatment Modalities for Skin Cancer by Adnan, Mohammad, Akhter, Md Habban, Afzal, Obaid, Altamimi, Abdulmalik S A, Ahmad, Irfan, Alossaimi, Manal A, Jaremko, Mariusz, Emwas, Abdul-Hamid, Haider, Tanweer, Haider, Md Faheem

    Published in Molecules (Basel, Switzerland) (01-08-2023)
    “…Cancer is a progressive disease of multi-factorial origin that has risen worldwide, probably due to changes in lifestyle, food intake, and environmental…”
    Get full text
    Journal Article
  3. 3

    Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics by Alamri, Mubarak A., Altharawi, Ali, Alabbas, Alhumaidi B., Alossaimi, Manal A., Alqahtani, Safar M.

    Published in Arabian journal of chemistry (01-09-2020)
    “…Coronavirus disease 2019 (COVID-19) has affected almost every country in the world by causing a global pandemic with a high mortality rate. Lack of an…”
    Get full text
    Journal Article
  4. 4

    Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer by Sarma, Kangkan, Akther, Md Habban, Ahmad, Irfan, Afzal, Obaid, Altamimi, Abdulmalik S A, Alossaimi, Manal A, Jaremko, Mariusz, Emwas, Abdul-Hamid, Gautam, Preety

    Published in Molecules (Basel, Switzerland) (29-02-2024)
    “…Lung cancer has the lowest survival rate due to its late-stage diagnosis, poor prognosis, and intra-tumoral heterogeneity. These factors decrease the…”
    Get full text
    Journal Article
  5. 5

    An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis by Altharawi, Ali, Alossaimi, Manal A., Alanazi, Mohammed M., Alqahatani, Safar M., Tahir ul Qamar, Muhammad

    Published in Scientific reports (28-04-2023)
    “…The acquired drug resistance by Mycobacterium tuberculosis (M. tuberculosis) to antibiotics urges the need for developing novel anti- M. tuberculosis drugs…”
    Get full text
    Journal Article
  6. 6

    Design, biological evaluation, and molecular modelling insights of cupressic acid derivatives as promising anti-inflammatory agents by Soliman, Amal F., Elimam, Diaaeldin M., El-Senduny, Fardous F., Alossaimi, Manal A., Alamri, Mubarak, Abdel Bar, Fatma M.

    “…The major labdanes in the oleogum resin of Araucaria heterophylla (Salisb.) Franco, 13-epi-cupressic acid (1) and acetyl-13-epi-cupressic acid (2) were used to…”
    Get full text
    Journal Article
  7. 7

    In Vitro and In Silico Investigation of Polyacetylenes from Launaea capitata (Spreng.) Dandy as Potential COX-2, 5-LOX, and BchE Inhibitors by Abdel Bar, Fatma M, Mira, Amira, Foudah, Ahmed I, Alossaimi, Manal A, Alkanhal, Shatha F, Aldaej, Alanoud M, ElNaggar, Mai H

    Published in Molecules (Basel, Switzerland) (17-04-2023)
    “…Diverse secondary metabolites are biosynthesized by plants via various enzymatic cascades. These have the capacity to interact with various human receptors,…”
    Get full text
    Journal Article
  8. 8

    Novel 2-Sulfanylquinazolin-4(3 H )-one Derivatives as Multi-Kinase Inhibitors and Apoptosis Inducers: A Synthesis, Biological Evaluation, and Molecular Docking Study by Altharawi, Ali, Alanazi, Mohammed M, Alossaimi, Manal A, Alanazi, Ashwag S, Alqahtani, Safar M, Geesi, Mohammed H, Riadi, Yassine

    Published in Molecules (Basel, Switzerland) (01-07-2023)
    “…The discovery of multi-targeted kinase inhibitors emerged as a potential strategy in the therapy of multi-genic diseases, such as cancer, that cannot be…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Synthesis, Anticancer Activity, and In Silico Studies of 5-(3-Bromophenyl)-N-aryl-4H-1,2,4-triazol-3-amine Analogs by Ahsan, Mohamed Jawed, Gautam, Krishna, Ali, Amena, Ali, Abuzer, Altamimi, Abdulmalik Saleh Alfawaz, Salahuddin, Alossaimi, Manal A., Lakshmi, S. V. V. N. S. M., Ahsan, Md. Faiyaz

    Published in Molecules (Basel, Switzerland) (05-10-2023)
    “…In the current study, we described the synthesis of ten new 5-(3-Bromophenyl)-N-aryl-4H-1,2,4-triazol-3-amine analogs (4a–j), as well as their…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    System biology approach to identify the novel biomarkers in glioblastoma multiforme tumors by using computational analysis by Alqahtani, Safar M, Altharawi, Ali, Alabbas, Alhumaidi, Ahmad, Faisal, Ayaz, Hassan, Nawaz, Asia, Rahman, Sidra, Alossaimi, Manal A

    Published in Frontiers in pharmacology (22-05-2024)
    “…The most common primary brain tumor in adults is glioblastoma multiforme (GBM), accounting for 45.2% of all cases. The characteristics of GBM, a highly…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Design, synthesis, molecular docking, and in vitro studies of 2-mercaptoquinazolin-4(3H)-ones as potential anti-breast cancer agents by Alossaimi, Manal A., Riadi, Yassine, Alnuwaybit, Ghaida N., Md, Shadab, Alkreathy, Huda Mohammed, Elekhnawy, Engy, Geesi, Mohammed H., Alqahtani, Safar M., Afzal, Obaid

    Published in Saudi pharmaceutical journal (01-03-2024)
    “…[Display omitted] •Quinazolinone derivatives were designed keeping Ispinesib and Idelalisib as reference structures.•Compounds 3a, 3b, 3e, 3g and 3h revealed…”
    Get full text
    Journal Article
  19. 19

    Pelargonium sidoides Root Extract: Simultaneous HPLC Separation, Determination, and Validation of Selected Biomolecules and Evaluation of SARS-CoV-2 Inhibitory Activity by Alossaimi, Manal A., Alzeer, May A., Abdel Bar, Fatma M., ElNaggar, Mai H.

    Published in Pharmaceuticals (Basel, Switzerland) (23-09-2022)
    “…This study aimed to establish a validated HPLC-UV analytical method for the determination of gallic acid, catechin, scopoletin, and umckalin in…”
    Get full text
    Journal Article
  20. 20

    Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats by AlRasheed, Hajer, Almomen, Aliyah, Aljohar, Haya I, Arafah, Maria, Almotawa, Rana Y, Alossaimi, Manal A, Alzoman, Nourah Z

    Published in Pharmaceuticals (Basel, Switzerland) (01-11-2022)
    “…Background: Erlotinib (ERL) and gefitinib (GEF) are extensively metabolized by CYP450 enzymes. Aspartame (ASP), an artificial sweetener, induces CYP2E1 and…”
    Get full text
    Journal Article